Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4HIC8
Term | Name | Level | Count |
---|---|---|---|
GO:0001522 | pseudouridine synthesis | 6 | 9 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 9 |
GO:0006364 | rRNA processing | 8 | 7 |
GO:0006396 | RNA processing | 6 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 9 |
GO:0006807 | nitrogen compound metabolic process | 2 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009451 | RNA modification | 5 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0016070 | RNA metabolic process | 5 | 9 |
GO:0016072 | rRNA metabolic process | 7 | 7 |
GO:0034470 | ncRNA processing | 7 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 9 |
GO:0034660 | ncRNA metabolic process | 6 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 9 |
GO:0043412 | macromolecule modification | 4 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
GO:0044238 | primary metabolic process | 2 | 9 |
GO:0046483 | heterocycle metabolic process | 3 | 9 |
GO:0071704 | organic substance metabolic process | 2 | 9 |
GO:0090304 | nucleic acid metabolic process | 4 | 9 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 9 |
GO:0000154 | rRNA modification | 6 | 1 |
GO:0000455 | enzyme-directed rRNA pseudouridine synthesis | 8 | 1 |
GO:0031118 | rRNA pseudouridine synthesis | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 9 |
GO:0003824 | catalytic activity | 1 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0009982 | pseudouridine synthase activity | 4 | 9 |
GO:0016853 | isomerase activity | 2 | 9 |
GO:0016866 | intramolecular transferase activity | 3 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 506 | 510 | PF00656 | 0.307 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.475 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.771 |
CLV_NRD_NRD_1 | 241 | 243 | PF00675 | 0.291 |
CLV_NRD_NRD_1 | 438 | 440 | PF00675 | 0.577 |
CLV_NRD_NRD_1 | 466 | 468 | PF00675 | 0.496 |
CLV_PCSK_FUR_1 | 436 | 440 | PF00082 | 0.521 |
CLV_PCSK_FUR_1 | 464 | 468 | PF00082 | 0.293 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.489 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.683 |
CLV_PCSK_KEX2_1 | 331 | 333 | PF00082 | 0.249 |
CLV_PCSK_KEX2_1 | 438 | 440 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 466 | 468 | PF00082 | 0.374 |
CLV_PCSK_PC1ET2_1 | 331 | 333 | PF00082 | 0.237 |
CLV_PCSK_PC7_1 | 462 | 468 | PF00082 | 0.365 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.332 |
CLV_PCSK_SKI1_1 | 331 | 335 | PF00082 | 0.251 |
CLV_PCSK_SKI1_1 | 467 | 471 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 474 | 478 | PF00082 | 0.372 |
CLV_Separin_Metazoa | 338 | 342 | PF03568 | 0.398 |
DEG_SCF_FBW7_1 | 174 | 180 | PF00400 | 0.668 |
DEG_SCF_FBW7_2 | 415 | 422 | PF00400 | 0.430 |
DOC_CKS1_1 | 174 | 179 | PF01111 | 0.680 |
DOC_CYCLIN_RxL_1 | 462 | 473 | PF00134 | 0.465 |
DOC_MAPK_gen_1 | 223 | 233 | PF00069 | 0.456 |
DOC_MAPK_gen_1 | 264 | 272 | PF00069 | 0.640 |
DOC_MAPK_MEF2A_6 | 438 | 447 | PF00069 | 0.532 |
DOC_PP1_RVXF_1 | 472 | 478 | PF00149 | 0.443 |
DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.415 |
DOC_PP4_FxxP_1 | 477 | 480 | PF00568 | 0.391 |
DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.422 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.499 |
DOC_USP7_MATH_1 | 235 | 239 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 258 | 262 | PF00917 | 0.497 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 319 | 323 | PF00917 | 0.514 |
DOC_USP7_MATH_1 | 347 | 351 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 524 | 528 | PF00917 | 0.553 |
DOC_USP7_MATH_2 | 356 | 362 | PF00917 | 0.398 |
DOC_WW_Pin1_4 | 173 | 178 | PF00397 | 0.760 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 415 | 420 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 480 | 485 | PF00397 | 0.551 |
DOC_WW_Pin1_4 | 490 | 495 | PF00397 | 0.443 |
LIG_14-3-3_CanoR_1 | 118 | 124 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 266 | 271 | PF00244 | 0.438 |
LIG_AP2alpha_2 | 442 | 444 | PF02296 | 0.444 |
LIG_BIR_III_2 | 206 | 210 | PF00653 | 0.212 |
LIG_BRCT_BRCA1_1 | 22 | 26 | PF00533 | 0.464 |
LIG_BRCT_BRCA1_1 | 273 | 277 | PF00533 | 0.472 |
LIG_BRCT_BRCA1_1 | 509 | 513 | PF00533 | 0.427 |
LIG_Clathr_ClatBox_1 | 280 | 284 | PF01394 | 0.382 |
LIG_eIF4E_1 | 106 | 112 | PF01652 | 0.404 |
LIG_eIF4E_1 | 84 | 90 | PF01652 | 0.451 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.655 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.569 |
LIG_FHA_1 | 189 | 195 | PF00498 | 0.499 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.477 |
LIG_FHA_1 | 254 | 260 | PF00498 | 0.517 |
LIG_FHA_1 | 291 | 297 | PF00498 | 0.523 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.523 |
LIG_FHA_1 | 318 | 324 | PF00498 | 0.466 |
LIG_FHA_1 | 490 | 496 | PF00498 | 0.333 |
LIG_FHA_1 | 516 | 522 | PF00498 | 0.490 |
LIG_FHA_2 | 132 | 138 | PF00498 | 0.571 |
LIG_KLC1_Yacidic_2 | 430 | 435 | PF13176 | 0.489 |
LIG_LIR_Apic_2 | 4 | 10 | PF02991 | 0.400 |
LIG_LIR_Gen_1 | 23 | 32 | PF02991 | 0.476 |
LIG_LIR_Gen_1 | 291 | 300 | PF02991 | 0.532 |
LIG_LIR_Gen_1 | 305 | 312 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 23 | 29 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 274 | 280 | PF02991 | 0.413 |
LIG_LIR_Nem_3 | 291 | 295 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 305 | 309 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 361 | 366 | PF02991 | 0.497 |
LIG_LIR_Nem_3 | 441 | 447 | PF02991 | 0.505 |
LIG_LYPXL_yS_3 | 406 | 409 | PF13949 | 0.420 |
LIG_PTB_Apo_2 | 49 | 56 | PF02174 | 0.326 |
LIG_PTB_Phospho_1 | 49 | 55 | PF10480 | 0.327 |
LIG_SH2_CRK | 292 | 296 | PF00017 | 0.481 |
LIG_SH2_CRK | 7 | 11 | PF00017 | 0.427 |
LIG_SH2_NCK_1 | 124 | 128 | PF00017 | 0.329 |
LIG_SH2_SRC | 84 | 87 | PF00017 | 0.469 |
LIG_SH2_STAP1 | 292 | 296 | PF00017 | 0.523 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.517 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.360 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.417 |
LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 433 | 436 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.482 |
LIG_SH3_3 | 202 | 208 | PF00018 | 0.682 |
LIG_SH3_3 | 350 | 356 | PF00018 | 0.519 |
LIG_SH3_3 | 440 | 446 | PF00018 | 0.554 |
LIG_SH3_3 | 518 | 524 | PF00018 | 0.542 |
LIG_SUMO_SIM_anti_2 | 227 | 235 | PF11976 | 0.456 |
LIG_SUMO_SIM_anti_2 | 85 | 93 | PF11976 | 0.480 |
LIG_TYR_ITIM | 404 | 409 | PF00017 | 0.420 |
LIG_UBA3_1 | 18 | 25 | PF00899 | 0.459 |
LIG_UBA3_1 | 218 | 226 | PF00899 | 0.398 |
LIG_WW_3 | 66 | 70 | PF00397 | 0.477 |
MOD_CDK_SPxK_1 | 415 | 421 | PF00069 | 0.624 |
MOD_CK1_1 | 122 | 128 | PF00069 | 0.616 |
MOD_CK1_1 | 351 | 357 | PF00069 | 0.466 |
MOD_CK1_1 | 493 | 499 | PF00069 | 0.328 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.518 |
MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.657 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.567 |
MOD_GlcNHglycan | 227 | 231 | PF01048 | 0.270 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.553 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.750 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.747 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.493 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.560 |
MOD_GSK3_1 | 341 | 348 | PF00069 | 0.529 |
MOD_GSK3_1 | 354 | 361 | PF00069 | 0.407 |
MOD_GSK3_1 | 454 | 461 | PF00069 | 0.583 |
MOD_GSK3_1 | 486 | 493 | PF00069 | 0.466 |
MOD_GSK3_1 | 503 | 510 | PF00069 | 0.419 |
MOD_GSK3_1 | 515 | 522 | PF00069 | 0.362 |
MOD_GSK3_1 | 524 | 531 | PF00069 | 0.569 |
MOD_N-GLC_1 | 51 | 56 | PF02516 | 0.327 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.525 |
MOD_NEK2_1 | 380 | 385 | PF00069 | 0.429 |
MOD_NEK2_1 | 413 | 418 | PF00069 | 0.443 |
MOD_NEK2_1 | 451 | 456 | PF00069 | 0.531 |
MOD_NEK2_1 | 470 | 475 | PF00069 | 0.422 |
MOD_NEK2_1 | 488 | 493 | PF00069 | 0.373 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.468 |
MOD_NEK2_2 | 119 | 124 | PF00069 | 0.304 |
MOD_PIKK_1 | 325 | 331 | PF00454 | 0.550 |
MOD_PIKK_1 | 351 | 357 | PF00454 | 0.479 |
MOD_PKA_1 | 117 | 123 | PF00069 | 0.398 |
MOD_PKA_1 | 24 | 30 | PF00069 | 0.327 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.578 |
MOD_PKA_2 | 458 | 464 | PF00069 | 0.445 |
MOD_PKB_1 | 264 | 272 | PF00069 | 0.360 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.401 |
MOD_Plk_1 | 14 | 20 | PF00069 | 0.509 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.636 |
MOD_Plk_1 | 185 | 191 | PF00069 | 0.657 |
MOD_Plk_1 | 51 | 57 | PF00069 | 0.317 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.489 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.406 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.500 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.474 |
MOD_Plk_4 | 258 | 264 | PF00069 | 0.420 |
MOD_Plk_4 | 302 | 308 | PF00069 | 0.523 |
MOD_Plk_4 | 493 | 499 | PF00069 | 0.345 |
MOD_Plk_4 | 51 | 57 | PF00069 | 0.480 |
MOD_ProDKin_1 | 173 | 179 | PF00069 | 0.760 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.498 |
MOD_ProDKin_1 | 415 | 421 | PF00069 | 0.503 |
MOD_ProDKin_1 | 480 | 486 | PF00069 | 0.545 |
MOD_ProDKin_1 | 490 | 496 | PF00069 | 0.449 |
TRG_DiLeu_BaEn_1 | 85 | 90 | PF01217 | 0.454 |
TRG_DiLeu_BaEn_2 | 301 | 307 | PF01217 | 0.523 |
TRG_DiLeu_BaEn_2 | 439 | 445 | PF01217 | 0.468 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.456 |
TRG_ENDOCYTIC_2 | 406 | 409 | PF00928 | 0.420 |
TRG_ER_diArg_1 | 181 | 183 | PF00400 | 0.716 |
TRG_ER_diArg_1 | 370 | 373 | PF00400 | 0.480 |
TRG_ER_diArg_1 | 436 | 439 | PF00400 | 0.474 |
TRG_ER_diArg_1 | 463 | 466 | PF00400 | 0.424 |
TRG_Pf-PMV_PEXEL_1 | 182 | 186 | PF00026 | 0.662 |
TRG_Pf-PMV_PEXEL_1 | 242 | 247 | PF00026 | 0.285 |
TRG_Pf-PMV_PEXEL_1 | 528 | 532 | PF00026 | 0.580 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IME7 | Leptomonas seymouri | 50% | 100% |
A0A0S4JCR9 | Bodo saltans | 29% | 89% |
A0A3Q8IFN9 | Leishmania donovani | 75% | 100% |
A4I5M1 | Leishmania infantum | 74% | 100% |
C9ZQZ4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9B0W6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 73% | 100% |
Q4Q7A0 | Leishmania major | 76% | 100% |